Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Lung Cancer Treatments and Mutations, and Immunotherapy and Immune Responses.
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation
An integrative proteomics method identifies a regulator of translation during stem cell maintenance and differentiation
Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection
The protein expression profile of ACE2 in human tissues
Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene
WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC
Cancer stemness, intratumoral heterogeneity, and immune response across cancers
A clonal expression biomarker associates with lung cancer mortality
LIPG‐promoted lipid storage mediates adaptation to oxidative stress in breast cancer
NK‐ and T‐cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti‐CTLA‐4 therapy
Platelet-derived growth factor receptor β activation and regulation in murine myelofibrosis
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
Expression of scavenger receptor <scp>MARCO</scp> defines a targetable tumor‐associated macrophage subset in non‐small cell lung cancer
Publisher Correction: Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer
Prognostic relevance of cancer-associated fibroblasts in human cancer
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer
Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors
CD99 is a novel prognostic stromal marker in non‐small cell lung cancer
Data-driven unbiased curation of the <i>TP53</i> tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors